Bioorthogonal Chemistry-Guided Inhalable Nanoprodrug to Circumvent Cisplatin Resistance in Orthotopic Nonsmall Cell Lung Cancer DOI
Lu Tang, Yue Yin,

Yuqi Cao

и другие.

ACS Nano, Год журнала: 2024, Номер 18(46), С. 32103 - 32117

Опубликована: Ноя. 9, 2024

Pulmonary delivery of anticancer therapeutics has shown encouraging performance in treating nonsmall cell lung cancer (NSCLC), which is characterized by high aggressiveness and poor prognosis. Cisplatin, a key member the family DNA alkylating agents, extensively employed during NSCLC therapy. However, development chemoresistance occurrence side effects severely impede long-term application cisplatin-based chemotherapies. Herein, we propose meaningful strategy to precisely treat cisplatin-resistant based on combination bioorthogonal chemistry with an inhalation approach. Ethacraplatin (EA-Pt), platinum prodrug (IV), was synthesized encapsulated nitric oxide (NO)-containing micelles overcome cisplatin chemoresistance. By further modifying molecules this nanoplatform (EA-Pt@M

Язык: Английский

Leveraging CRISPR/Cas9 in notable bacteria for the production of industrially valuable compounds DOI

Md Dilshad Karim,

Md. Abuhena,

Lutfur Rahman

и другие.

Systems Microbiology and Biomanufacturing, Год журнала: 2025, Номер unknown

Опубликована: Янв. 14, 2025

Язык: Английский

Процитировано

1

Microneedle patch-involved local therapy synergized with immune checkpoint inhibitor for pre- and post-operative cancer treatment DOI
Yue Yin, Lu Tang,

Yuqi Cao

и другие.

Journal of Controlled Release, Год журнала: 2025, Номер 379, С. 678 - 695

Опубликована: Янв. 24, 2025

Язык: Английский

Процитировано

1

Photoresponsive Multirole Nanoweapon Camouflaged by Hybrid Cell Membrane Vesicles for Efficient Antibacterial Therapy of Pseudomonas aeruginosa‐Infected Pneumonia and Wound DOI Creative Commons
Hening Liu,

Lu Tang,

Yue Yin

и другие.

Advanced Science, Год журнала: 2024, Номер unknown

Опубликована: Июль 15, 2024

Exploring effective antibacterial approaches for targeted treatment of pathogenic bacterial infections with reduced drug resistance is great significance. Combinational modality that leverages different therapeutic components can improve the overall effectiveness and minimize adverse effects, thus displaying considerable potential against infections. Herein, red blood cell membrane fuses macrophage to develop hybrid shell, which further camouflages around drug-loaded liposome fabricate biomimetic (AB@LRM) precise therapy. Specifically, photoactive agent black phosphorus quantum dots (BPQDs) classical antibiotics amikacin (AM) are loaded in AB@LRM accurately target inflammatory sites through guidance long residence capability membrane, eventually exerting efficacious activities. Besides, due excellent photothermal photodynamic properties, BPQDs act as an efficient when exposed near-infrared laser irradiation, dramatically increasing sensitivity bacteria antibiotics. Consequently, synergistic sterilizing effect produced by restricts resistance. Upon shows superior anti-inflammatory properties models P. aeruginosa-infected pneumonia wounds. Hence, this light-activatable nanoplatform good biocompatibility presents advance clinical development

Язык: Английский

Процитировано

7

Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside DOI
Yijun Mei,

Jingyi Hu,

Yuanyuan Cao

и другие.

Applied Materials Today, Год журнала: 2024, Номер 39, С. 102341 - 102341

Опубликована: Июль 22, 2024

Язык: Английский

Процитировано

5

Black phosphorus-based nanoplatforms for cancer therapy: chemistry, design, biological and therapeutic behaviors DOI Creative Commons
Ashkan Bigham, Manuel Serrano‐Ruiz, Maria Caporali

и другие.

Chemical Society Reviews, Год журнала: 2024, Номер unknown

Опубликована: Дек. 2, 2024

Black phosphorus nanomaterials have opened new doors to cancer therapy. They can induce anticancer activities intrinsically (selectively) and/or with external stimuli (PTT, PDT, SDT, etc. ) and are highly suitable for drug/gene delivery.

Язык: Английский

Процитировано

5

Emerging Violet Phosphorus Nanomaterial for Biomedical Applications DOI Open Access
Yijun Mei,

Yuanyuan Cao,

Wei Wang

и другие.

Advanced Healthcare Materials, Год журнала: 2025, Номер unknown

Опубликована: Янв. 10, 2025

Abstract Violet phosphorus (VP) is a allotrope first discovered by Hittorf in 1865, which has aroused more attention the biomedical field recent years attributed to its gradually unique properties. VP can be further categorized into bulk VP, nanosheets (VPNs), and quantum dots (VPQDs), chemical vapor transport (CVT), liquid‐phase/mechanical/laser exfoliation, solvothermal synthesis are common preparation approaches of VPNs, VPQDs, respectively. Compared with another (black phosphorus, BP) that once highly regarded applications, nanomaterial (namely VPNs VPQDs) not only exhibits tunable bandgap, moderate on/off current ratio, good biodegradability, but shows enhanced stability biosafety as well, allowing it promising candidate for variety applications like antibacterial therapy, anticancer biosensing disease diagnosis. In this review, classification relevant routes initially summarized, properties momentous subsequently expounded. The latest research advances emerging then introduced detail, both existing challenges future prospects also discussed.

Язык: Английский

Процитировано

0

Application of nanoparticles to target tumor blood vessels as a promising cancer treatment strategy DOI

Patryk Lorenc,

Hanna Dams-Kozłowska,

Natalia Guzniczak

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2025, Номер 186, С. 118038 - 118038

Опубликована: Апрель 10, 2025

Язык: Английский

Процитировано

0

Micro/nano system-mediated local treatment in conjunction with immune checkpoint inhibitor against advanced-Stage malignant melanoma DOI
Lu Tang, Hening Liu, Yue Yin

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 497, С. 154499 - 154499

Опубликована: Авг. 3, 2024

Язык: Английский

Процитировано

4

Photothermally Active Quantum Dots in Cancer Imaging and Therapeutics: Nanotheranostics Perspective DOI
Monalisha Debnath, Sayoni Sarkar, Sujit Kumar Debnath

и другие.

ACS Applied Bio Materials, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 11, 2024

Cancer is becoming a global threat, as the cancerous cells manipulate themselves frequently, resulting in mutants and more abnormalities. Early-stage real-time detection of cancer biomarkers can provide insight into designing cost-effective diagnostic therapeutic modalities. Nanoparticle quantum dot (QD)-based approaches have been recognized clinically relevant methods to detect disease at molecular level. Over decades, an emergent noninvasive approach, photothermal therapy has evolved eradicate cancer. Moreover, various structures, viz., nanoparticles, clusters, dots, etc., tested bioimaging agents identify tumor selectively. Among them, QDs versatile probes. They attracted enormous attention for imaging applications due their unique colloidal stability, optical physicochemical properties, biocompatibility, easy surface conjugation, scalable production, etc. However, few critical concerns QDs, precise engineering sensing, selective interaction with biological system, associated toxicity, restrict potential intervention curing are yet be explored. According U.S. Food Drug Administration (FDA), there no specific regulation approval nanomedicines. Therefore, these nanomedicines undergo traditional drug, biological, device process. market survey increasing, prospects translational nanomedicine very promising. From this perspective, we discuss importance imaging, usage pertinent cancer, especially its early stages. also rapidly growing view QDs. The long-term safety studies cellular could enhance visibility bring photothermally active clinical stage concurrently FDA approval.

Язык: Английский

Процитировано

4

Recent progress on transition metal dichalcogenide-based composites for cancer therapy DOI
Bo Chen, Yue Dai, S.‐Y. Yang

и другие.

Nanoscale, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Cancer remains a global health challenge, driving the need for advanced treatments. While transition metal dichalcogenides (TMDs) show promise in cancer therapy, their stability and efficacy require improvement. This study explores TMD-based composites as solution to enhance therapeutic potential. review begins by providing an overview of TMDs emphasizing preparation techniques fundamental properties. The focus is then shifted categorizing based on constituent materials, delving into various types, such TMD-organic, TMD-carbon, TMD-metal chalcogenide, TMD-metal, TMD-oxide composites, well more complex ternary multinary systems. We further explore key fabrication strategies, including hydrothermal/solvothermal methods surface deposition/coating techniques. Subsequently, applications treatment, chemotherapy, photothermal phototherapy, integrated combination therapies. Finally, critical challenges field perspectives potential directions future research are presented.

Язык: Английский

Процитировано

0